3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
University College Dublin · Imperial College London · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
839
total citations
- FWCI
- 41.35
- Percentile
- 100%
- References
- 33
Citations per year
Authors
202Topics & keywords
Topics
Keywords
- Prediabetes
- Liraglutide
- Medicine
- Placebo
- Type 2 diabetes
- Diabetes mellitus
- Internal medicine
- Weight loss
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.